Aurobindo Pharma is currently trading at Rs. 185.20, up by 2.40 points or 1.31% from its previous closing of Rs. 182.80 on the BSE.
The scrip opened at Rs. 182.95 and has touched a high and low of Rs. 188.95 and Rs. 179.50 respectively. So far 212376 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 204.90 on 03-Jan-2013 and a 52 week low of Rs. 111.15 on 03-Sep-2012.
Last one week high and low of the scrip stood at Rs. 188.95 and Rs. 163.35 respectively. The current market cap of the company is Rs. 5470.40 crore.
The promoters holding in the company stood at 54.84 % while Institutions and Non-Institutions held 31.65% and 13.51% respectively.
Macquarie Bank has sold 19,40,000 shares of Aurobindo Pharma through an open market transaction. The shares were sold at an average price of Rs 180.97 on National Stock Exchange (NSE) on August 29, 2013.
Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.
